Ronald Orol leads The Deal's coverage of activist hedge fund managers, a high-profile group of corporate investors who press for blockbuster deals and were the subject of his book “Extreme Value Hedging: How Activist Hedge Fund Managers are Taking on the World.” Orol also specializes in reporting on bank and securities regulation in the wake of the 2008 financial crisis. Orol’s reporting covers a wide range of Washington issues critical to dealmaking, including financial reform, Securities and Exchange Commission rules impacting IPOs and mergers and federal oversight of bank transactions. Orol is an occasional commentator on TheStreet TV, BBC World Television and National Public Radio.
Recent Articles By The Author
P&G's CEO Hypes Skin Lotion Innovation as Activist Peltz Arrives to Board
The insurgent investor is set to join the iconic packaged goods company's key innovation panel. Expect a hostile reception.
Activist Urges Outback Steakhouse Owner to Spin Off Chains
Barington Capital's Jim Mitarotonda says Outback Steakhouse's parent company, Bloomin' Brands, has become too complicated. He wants it to spin off smaller chains, including Bonefish Grill.
Why Activist Investors Won't Target UPS Even After Lackluster Results
The shipping giant's shares continue to slide, so why are insurgent fund managers hesitating?
Qualcomm's Higher NXP Bid Secures OK From Elliott Management's Paul Singer
The deal brings the chipmaker one step closer to closing its semiconductor purchase and it also makes life more complicated for Broadcom, which just secured a key recommendation for four of the six dissident director candidates it is seeking to install on Qualcomm's board.
Broadcom Dealt a New Blow in Battle to Buy Qualcomm
The influential investment advisory firm Institutional Shareholders Services recommended that investors support a minority-slate of four of six dissident nominees Broadcom is seeking to install onto the board of the chipmaker, which was a major blow for the chipmaker's hostile bid.